AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $227,000 | -75.0% | 14,959 | -66.8% | 0.10% | -24.6% |
Q1 2018 | $907,000 | +9.4% | 45,019 | -28.0% | 0.13% | +26.0% |
Q4 2017 | $829,000 | -70.3% | 62,556 | -58.7% | 0.10% | -67.2% |
Q3 2017 | $2,794,000 | +103.5% | 151,442 | +103.0% | 0.30% | +82.6% |
Q2 2017 | $1,373,000 | – | 74,600 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |